Apoptosis-based therapies for hematologic malignancies
- PMID: 15797997
- DOI: 10.1182/blood-2004-07-2761
Apoptosis-based therapies for hematologic malignancies
Abstract
Apoptosis is an intrinsic cell death program that plays critical roles in tissue homeostasis, especially in organs where high rates of daily cell production are offset by rapid cell turnover. The hematopoietic system provides numerous examples attesting to the importance of cell death mechanisms for achieving homeostatic control. Much has been learned about the mechanisms of apoptosis of lymphoid and hematopoietic cells since the seminal observation in 1980 that glucocorticoids induce DNA fragmentation and apoptosis of thymocytes and the demonstration in 1990 that depriving colony-stimulating factors from factor-dependent hematopoietic cells causes programmed cell death. From an understanding of the core components of the apoptosis machinery at the molecular and structural levels, many potential new therapies for leukemia and lymphoma are emerging. In this review, we introduce some of the drug discovery _targets thus far identified within the core apoptotic machinery and describe some of the progress to date toward translating our growing knowledge about these _targets into new therapies for cancer and leukemia.
Similar articles
-
The rise of apoptosis: _targeting apoptosis in hematologic malignancies.Blood. 2018 Sep 20;132(12):1248-1264. doi: 10.1182/blood-2018-02-791350. Epub 2018 Jul 16. Blood. 2018. PMID: 30012635 Review.
-
_targeting the mitochondrial apoptotic pathway: a preferred approach in hematologic malignancies?Cell Death Dis. 2014 Mar 6;5(3):e1098. doi: 10.1038/cddis.2014.61. Cell Death Dis. 2014. PMID: 24603326 Free PMC article. Review.
-
_targeting apoptosis proteins in hematological malignancies.Cancer Lett. 2013 May 28;332(2):325-34. doi: 10.1016/j.canlet.2011.06.016. Epub 2011 Jun 30. Cancer Lett. 2013. PMID: 21767908 Review.
-
Cell death _targeting therapies in B lymphoid malignancies.Curr Drug _targets. 2010 Jul;11(7):769-80. doi: 10.2174/138945010791320863. Curr Drug _targets. 2010. PMID: 20370650 Review.
-
Involvement of BH3-only proteins in hematologic malignancies.Crit Rev Oncol Hematol. 2009 Aug;71(2):89-101. doi: 10.1016/j.critrevonc.2008.10.004. Epub 2008 Nov 20. Crit Rev Oncol Hematol. 2009. PMID: 19022681 Review.
Cited by
-
Human umbilical cord matrix-derived stem cells expressing interferon-β gene inhibit breast cancer cells via apoptosis.Onco_target. 2016 Jun 7;7(23):34172-9. doi: 10.18632/onco_target.8997. Onco_target. 2016. PMID: 27129156 Free PMC article.
-
Cytotoxicity of methanol extracts of Elaeis guineensis on MCF-7 and Vero cell lines.Asian Pac J Trop Biomed. 2012 Oct;2(10):826-9. doi: 10.1016/S2221-1691(12)60237-8. Asian Pac J Trop Biomed. 2012. PMID: 23569855 Free PMC article.
-
Apoptosis in leukemias: regulation and therapeutic _targeting.Cancer Treat Res. 2010;145:197-217. doi: 10.1007/978-0-387-69259-3_12. Cancer Treat Res. 2010. PMID: 20306253 Free PMC article. Review.
-
Antiproliferative effects of different plant parts of Panax notoginseng on SW480 human colorectal cancer cells.Phytother Res. 2009 Jan;23(1):6-13. doi: 10.1002/ptr.2383. Phytother Res. 2009. PMID: 19048608 Free PMC article.
-
High Erk-1 activation and Gadd45a expression as prognostic markers in high risk pediatric haemolymphoproliferative diseases.J Exp Clin Cancer Res. 2009 Mar 19;28(1):39. doi: 10.1186/1756-9966-28-39. J Exp Clin Cancer Res. 2009. PMID: 19298651 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
